Skip to main content
. 2025 Jul 28;39(15):2768–2773. doi: 10.1038/s41433-025-03945-5

Table 1.

Demographics of patients who developed ERM versus those who did not after peripheral retinal laser photocoagulation.

Characteristics Patients without ERM Patients developing ERM P valued
Number of eyes 694 32 /
Age (years)a 36.6 ± 17.3 53.9 ± 11.1 <0.001
Sex 0.388
 Female 347 (50.0%) 19 (59.4%)
 Male 347 (50.0%) 13 (40.6%)
BCVA (logMAR)a 0.18 ± 0.06 0.20 ± 0.06 0.502
IOP (mmHg)a 15.5 ± 3.4 14.4 ± 2.9 0.075
Pseudophakic eyes 26 (3.74%) 1 (3.12%) 0.873
Diagnosis <0.001
 Lattice degeneration 280 (40.3%) 20 (62.5%)
 Other types of degenerationb 414 (59.7%) 12 (37.5%)
High myopiac 112 (16.1%) 11 (34.4%) 0.440
Use of anti-inflammatory agents after laser photocoagulation (%)e 255 (36.7%) 7 (21.9%) 0.087

aData were presented as mean ± standard deviation.

bOther types of retinal degeneration include paving stone degeneration, reticular degeneration, cystoid degeneration, and frosted branch angiitis-like degeneration.

cHigh myopia refers to a refractive error of <−6.00 dioptres or an axial length of over 26 mm.

dData were analysed using an independent samples t-test for continuous variables and for using a chi-square test for categorical variables. P values of <0.05 were considered significant.

eAnti-inflammatory agents refer to nonsteroidal anti-inflammatory eye drops, including pranoprofen, diclofenac sodium, and bromfenac sodium.

ERM epiretinal membrane, BCVA best-corrected visual acuity, logMAR Logarithm of the Minimum Angle of Resolution, IOP intraocular pressure.